Navigation Links
New Web Site to Raise Awareness for the Myanmar Crisis Has Lofty Goals
Date:5/9/2008

SAN DIEGO, May 9 /PRNewswire/ -- Summary: With the recent devastating cyclone in Myanmar causing an estimated 100,000 deaths and leaving over a million people homeless, the need for relief aid is immense. Internet entrepreneurs Sharon Tucci and Steve Jones have launched the Myanmar Challenge, a grassroots effort to award awareness for humanitarian needs, with hopes of filling the need as much as possible. Setting an initial goal of having 1,000 individuals and companies take the Myanmar Challenge, Tucci and Jones hope to create the exposure and relief contributions necessary to save thousands more victims of the cyclone.

An estimated 100,000 people have perished due to the devastating cyclone that hit Myanmar, the largest country by geographical area in Southeast Asia. Two Internet entrepreneurs, Sharon Tucci and Steve Jones, have risen to the call of community support by launching the Myanmar Challenge website. The objective of the site is to increase awareness of the situation in which millions are finding themselves without many things we take for granted -- such as food, clean water and shelter.

The Myanmar Challenge asks companies doing business online to pledge their support by offering either direct donations to one of the many relief organizations working in the affected region or by offering pledges based on purchases made at their websites by individuals. Tucci and Jones have set a goal of having 1,000 individuals and companies take the Myanmar Challenge.

"If each of these 1,000 individuals and companies only contribute $10 each," said Tucci, "That could potentially help save several hundred lives. That makes every minute spent on this endeavor worth it."

"We truly want to increase awareness of the devastation," added Jones. "Unfortunately, other news in the mainstream in much of the U.S. and other countries is overshadowing Myanmar's tragic situation. We want to challenge people to make a difference and to spread the wor
'/>"/>

SOURCE Steve Jones
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Acrylamide Raises Kidney Cancer Risk
2. HRSA Outreach Seeks to Raise Cancer Awareness Among People Who Lived Near Nuclear Sites or Mined Uranium
3. National Lung Cancer Partnership Launches Campaign to Raise Lung Cancer Awareness Among Women
4. Patients, Doctors, Pharmacists Praise Bipartisan House Resolution on Compounded Hormones Containing Estriol
5. Television Actor Who Has Portrayed a Doctor and an Investigator Lends Support to Fundraiser for the Toughest Childrens Cancer
6. West Coast Bank Sponsors Reach the Beach Cycling Fundraiser to Support the American Lung Association
7. The Childrens Heart Foundation Teams Up With ProFlowers(R) to Raise Awareness and Funding for the Leading Birth Defect in America
8. Reese Witherspoon Helps Celebrate Avon Walk for Breast Cancer Washington, D.C. - Weekend-Long Event Raises $8.1 Million
9. Relay Team Runs to Raise Funds for the American Cancer Society
10. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
11. Study raises questions about prostate cancer therapies targeting IGF-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...ces of Pay-for-Performance Programs , At a time ...g, this study finds that while such programs may s...ng physician income, they also change the nature o...rses work together. In-depth interviews with 41 fa...ingdom three years after implementation of a new p...
(Date:5/11/2008)...y 11 /PRNewswire/ -- The Myanmar Relief Fund,( htt...private American and,Myanmar citizens that have th...ms bypassing bureaucratic barriers. Teams of docto...ies are being distributed., The Myanmar Relief Fu...citizens with headquarters in California and Yango...
(Date:5/11/2008)...Biotechnology and Biological Sciences Research Cou...o investigate important aspects of human ageing. ...niversity, Dr Lynne Cox and Dr Robert Saunders hav...s can now be used to study the effects ageing has ...l Aging Cell, the researchers demonstrate the valu...
(Date:5/11/2008)... 20). Senior White House Correspondent Richard,Wol... at the presidential,candidate,s leadership and ma...or the coming mud war with John McCain and the Rep...ll be about the big issues because there,are stark...e economy.,They,re also ready for attacks from ano...
Breaking Medicine News(10 mins):Health News:May/June 2008 Annals of Family Medicine tip sheet 2Health News:May/June 2008 Annals of Family Medicine tip sheet 3Health News:May/June 2008 Annals of Family Medicine tip sheet 4Health News:May/June 2008 Annals of Family Medicine tip sheet 5Health News:May/June 2008 Annals of Family Medicine tip sheet 6Health News:Human aging gene found in flies 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 4Health News:NEWSWEEK: Media Lead Sheet/May 19, 2008 Issue (on newsstands Monday, May 12, 2008) 5
...bec had a man made heart implanted inside him l...// who does not have a heart beat! “Heartmate II”... Langevin by Dr. Renzo Cecere and Dr Nadia Giannet...006.This device,is expected to function for at lea...
...izophrenia have greater chances of getting cardiov...seases when compared with those without mental// i...ovember 2006 issue of the Journal of General Inter...er piece in the larger puzzle of understanding the...
...l thesis from Karolinska Institutet, almost quarte...tinence, one year after childbirth.// However, des...er self-rated health than other women in the same ...h after childbirth, postgraduate student and midwi...
...rch UK has suggested that certain Christmas toys a...his was revealed when 14 toys out of the 15 that//...were higher than the prescribed safety limits of 8...iest were found to be toy guns, which included a m...
Other Medicine News:Health News:Schizophrenics At Greater Risk Of Developing Chronic Diseases 2Health News:Exertion Incontinence - A Common Postnatal Problem 2Health News:Toy Story Turns Bitter-Christmas Toys, No Music to the Ears! 2
(Date:5/8/2008)...oan-Kettering Cancer Center Investigators to Asses...an Cancer Patients -, BRISBANE, Calif., May 8 /PR...the expansion of Phase 2 clinical trial programs f...his is the third major clinical trial,of BSI-201 t...ding on,on-going trials in breast and brain cancer...
(Date:5/8/2008)...y 8 /- Go Healthy (Pink She...nical trials with Cholesterade (R),in three medica... of 200,patients in 6 centers around the country. ... at The Methodist Hospital in the Texas Medical Ce... was formerly the Team,Physician for the Houston A...
(Date:5/7/2008)...May 7 /- Arena Pharmaceutic...isho Pharmaceutical Co., Ltd.,initiated a Phase 1 ...cused,partnership with Arena to develop compounds ... is a novel oral compound intended for the treatme...y happy to see our long-standing partner, Taisho,...
(Date:5/7/2008)... May 7 /- Shire plc (LSE: S...ceutical company, presented,today at a major scien...ial,results of INTUNIV, a selective alpha-2A-agoni... medication, which is being evaluated for the,trea...tivity Disorder,(ADHD). The data demonstrated that...
Breaking Medicine Technology:BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Go Healthy Initiates Additional Clinical Tests on Cholesterade 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 2Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd. 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6HSA Plans Gain Popularity as Premium Costs Rise 2129 1HSA Plans Gain Popularity as Premium Costs Rise 2129 2Ikaria Founding Scientist Named 2007 MacArthur Fellow 867 1Ikaria Founding Scientist Named 2007 MacArthur Fellow 867 2Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2123 1Delmarva Foundation Implements Medication Therapy Management Program in Maryland and DC 2123 2Mustafa alAbsi Ph D and national team awarded major NIH grant 582 1Mustafa alAbsi Ph D and national team awarded major NIH grant 582 2
... * Preclinical study evaluating a clinically relev...e was the only agent capable,of abrogating the cyt...Marqibo(r) showed OPTISOME(tm) agent was generally...th an adverse event,profile similar to conventiona...4, 2007 (PRIME NEWSWIRE) --,Hana Biosciences (Nasd...
...BERKELEY HEIGHTS, NJ – June 4, 2007 – ...esentation of results,from a Phase 2 clinical tria...trate injection), plus rituximab (Rituxan®;,Ge...elapsed or,refractory non-Hodgkin’s lymphoma...ing of the American Society of Clinical,Oncology (...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5
Hydrophilic Acrylic Intraocular Lens (Refractive and Bifocal). Anterior Chamber Lens.
Raysoft Foldable Intraocular Lens.
HAPTIBAG Hydrophilic Acrylic Lens.
Hydrophilic Acrylic Intraocular Lens, AC depth: 4.65.
Medicine Products: